Is it Possible to Predict The Market Access of a New Pharmaceutical in Germany? A Systematic Evaluation of Federal Joint Committee Decisions on Early Benefit Assessments According to The German Law For Reforming The Market of Pharmaceutical ...
Abstract
Authors
B. Schwander K. Banz K. Kaier S. Walzer